1. TIVICAY® (TIV-eh-kay) (Dolutegravir) 2. Date of Approval: August 12, 2013 Approved by :U.S. Food and Drug Administration (FDA) Company: ViiV Healthcare Generic Name :…
1. Unity's Response to the HIV Epidemic Andrew Catanzaro, MD Unity Health Care, Inc. 2. Overview Unity Health Care, Inc. History, Mission, Vision Patient demographics…
Slide 1 Slide 2 Slide 3 Location of the Integrated Care Clinic ¨Dr. Issac Cohen Alcahé¨ Slide 4 Principal Areas where Indigenous Peoples live Slide 5 Issue: Official AIDS…
1. Every 9 seconds in the US a woman is assaulted or beaten. Women ages 20-24 are at the greatest risk of nonfatal intimate partner violence. Victims lose nearly…
1. HIV at 30: History and Future Kathleen E. Squires, M.D.Professor of MedicineDirector, Division of Infectious Diseases Thomas Jefferson University and HospitalPresented…
1. Antiviral DrugsHarindu Udapitiya.Temporary Lecturer,Division Of Pharmacology,Department of Oral Medicine & Periodontology. 2. Overview• 1.Introduction to virus and…
Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa T. A. Thomas*,†,‡, S. V. Shenoi*,§, S. K. Heysell*,†,‡,…
1. Joseph J. Eron, Jr., MD University of North Carolina Chapel Hill, North Carolina Daniel R. Kuritzkes, MD Brigham and Women’s Hospital Harvard Medical School Boston,…
Slide 1 Metabolic Complications of HIV Dr Lou Haenel, Jr Endocrinology 12/10 Slide 2 Terminology LipodystrophyLipoatrophyLipohypertrophyHIV HAART (Highly Active Anti-Retroviral…
Slide 1 Management of Hepatitis B & HIV Co-infection in the Incarcerated Patient: A Clinical Update Douglas G. Fish, MD Head, Division of HIV Medicine Albany Medical…